Your browser doesn't support javascript.
loading
Remifentanil attenuates lipopolysaccharide-induced oxidative injury by downregulating PKCß2 activation and inhibiting autophagy in H9C2 cardiomyocytes.
Lei, Shaoqing; Zhang, Yuan; Su, Wating; Zhou, Lu; Xu, Jinjin; Xia, Zhong-Yuan.
Afiliação
  • Lei S; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zhang Y; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Su W; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Zhou L; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Xu J; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: jjxsabrina@163.com.
  • Xia ZY; Department of Anaesthesiology, Renmin Hospital of Wuhan University, Wuhan, China. Electronic address: xiazhongyuan2005@aliyun.com.
Life Sci ; 213: 109-115, 2018 Nov 15.
Article em En | MEDLINE | ID: mdl-30352239
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Quinase C beta / Remifentanil Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Quinase C beta / Remifentanil Idioma: En Ano de publicação: 2018 Tipo de documento: Article